Classification Term: 312

2-phenylindoles (ontology term: CHEMONTID:0003214)

Indoles substituted at the 2-position with a phenyl group." []

found 15 associated metabolites at category metabolite taxonomy ontology rank level.

Ancestor: Indoles

Child Taxonomies: There is no child term of current ontology term.

1-Methyl-2-phenylindole

1-methyl-2-phenyl-1H-indole

C15H13N (207.1047938)

1H-Indole-4,6-diamine, 2-phenyl-

C14H13N3 (223.1109418)

1H-Indole-4,6-dicarboximidamide, 2-phenyl-

C16H15N5 (277.132739)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

2-Phenylindole

alpha-Phenylindole potassium salt

C14H11N (193.0891446)

Bazedoxifene

1-({4-[2-(azepan-1-yl)ethoxy]phenyl}methyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol

C30H34N2O3 (470.2569294)

G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XC - Selective estrogen receptor modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D050071 - Bone Density Conservation Agents C1892 - Chemopreventive Agent

4',6-Diamidino-2-phenylindole

2-(4-(Aminoiminomethyl)phenyl)-1H-indole-6-carboximidamide

C16H15N5 (277.132739)

Diamidino-2-phenylindole

2-phenyl-1H-indole-3,4-dicarboximidamide

C16H15N5 (277.132739)

6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole

C20H19N5 (329.16403740000004)

N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide

2-[2-(4-fluorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide

C28H37FN2O (436.28897639999997)

1-(2-Azabicyclo[2.2.2]octan-2-yl)-2-[2-(3,5-dimethylphenyl)-3-[(2S)-1-(2-pyridin-2-ylethylamino)propan-2-yl]-1H-indol-5-yl]-2-methylpropan-1-one

C37H46N4O (562.3671426)

Indo-1 pentaacetoxymethyl ester

(acetyloxy)methyl 2-({2-[(acetyloxy)methoxy]-2-oxoethyl}(2-{2-[5-(6-{[(acetyloxy)methoxy]carbonyl}-1H-indol-2-yl)-2-[bis({2-[(acetyloxy)methoxy]-2-oxoethyl})amino]phenoxy]ethoxy}-4-methylphenyl)amino)acetate

C47H51N3O22 (1009.2964066)

D064449 - Sequestering Agents > D002614 - Chelating Agents

(Tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine

C24H29N3O3S (439.1929524000001)

Rubraca

6-fluoro-2-{4-[(methylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13)-tetraen-9-one

C19H18FN3O (323.14338300000003)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

4-(1H-Indol-2-yl)benzene-1,3-diamine

C14H13N3 (223.1109418)

4',6'-Diamidino-2-phenylindole

4-(1H-indol-2-yl)benzene-1,3-dicarboximidamide

C16H15N5 (277.132739)